EGFR and cancer: Furthermore, if PIK3CA mutation(s) caused resistance to EGFR TKI, the cancer cells with PIK3CA mutation would proliferates with tumor progression; therefore the population of PIK3CA mutant cells would increase and not be in low percentage mosaicism.